Potent Phosphatidylinositol 3-Kinase Inhibitors and Their Biology

ISSN: 1875-6220 (Online)
ISSN: 1570-1638 (Print)

Volume 14, 4 Issues, 2017

Download PDF Flyer

Current Drug Discovery Technologies

This journal supports open access

Aims & ScopeAbstracted/Indexed in

Submit Abstracts Online Submit Manuscripts Online

Vladimir P. Torchilin
Department of Pharmaceutical Science Center
for Pharmaceutical Biotechnology and Nanomedicine
Northeastern University
Boston, MA 02115

View Full Editorial Board

Subscribe Purchase Articles Order Reprints

Potent Phosphatidylinositol 3-Kinase Inhibitors and Their Biology

Current Drug Discovery Technologies, 11(2): 113-126.

Author(s): Mukesh Chandra Joshi, Krishan Kumar and Vikrant Kumar.

Affiliation: Department of Chemistry, Motilal Nehru College, University of Delhi, Delhi-110021, India.


The Phosphoinositide 3-kinase (PI3k) is an important regulator of intracellular signalling pathways, like cell proliferation, migration, survival, and angiogenesis upon activation by growth factor or receptors. The PI3k’s pathway is frequently up-regulated in human cancers, thus inhibition of PI3k’s is a promising approach for cancer therapy. Many potent PI3k’s inhibitors have been reported so far and few of them are in clinical trial like GDC-0941, BGT-226, AZD-6482 and others are natural products etc.


Clinical trial, glioblastoma cell lines, leukemia and lymphoma cell lines, phosphoinositide 3-kinase, proliferation, tumor inhibitors.

Purchase Online Order Reprints Order Eprints Rights and Permissions

Article Details

Volume: 11
Issue Number: 2
First Page: 113
Last Page: 126
Page Count: 14
DOI: 10.2174/1570163810666131229130207
Price: $58

Related Journals

Webmaster Contact: urooj@benthamscience.org Copyright © 2016 Bentham Science